C-C趋化因子受体6型
20立方厘米
RAR相关孤儿受体γ
医学
外周血单个核细胞
关贸总协定3
免疫学
白细胞介素17
T细胞
CXCR3型
趋化因子
流式细胞术
滑液
类风湿性关节炎
趋化因子受体
细胞因子
骨关节炎
转录因子
病理
FOXP3型
炎症
免疫系统
生物
体外
生物化学
基因
替代医学
作者
Shunta Kaneko,Yuya Kondo,Masahiro Yokosawa,Kotona Furuyama,Seiji Segawa,Hiroto Tsuboi,Akira Kanamori,Isao Matsumoto,Masashi Yamazaki,Takayuki Sumida
标识
DOI:10.1080/14397595.2017.1416923
摘要
To clarify the pathogenic role of transcription factor expression of CD4 + T helper (Th) cell subsets in the development of rheumatoid arthritis (RA).We collected CD4 + T cells from peripheral blood mononuclear cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) by magnetic cell sorting. The proportion of Th cell subsets were classified from cell surface markers (CD45RA, CXCR5, CXCR3, CCR6) and the expression of their transcription factors (T-bet, GATA3, RORγt) were analyzed by flow cytometry before and at 24 weeks after anti-rheumatic treatment. Chemotaxis assays quantified migratory ability.The expression of CCR6 and RORγt in Th17 cells from PBMC of RA patients was significantly higher than in healthy control volunteers and osteoarthritis patients. The proportion of Th17 cells in SFMCs of RA patients was significantly higher than that in PBMCs. Chemotaxis assays revealed that the migration index of Th17 cells towards CCL20 was remarkably enhanced in RA patients. The expression of CCR6 and RORγt in Th17 cells at 24 weeks post-therapeutic intervention was significantly decreased compared to before treatment.The high expression of RORγt might facilitate the migration of Th17 cells to inflamed joints via the enhanced expression of CCR6 and contribute to the pathology of RA.
科研通智能强力驱动
Strongly Powered by AbleSci AI